Recruitment

Recruitment Status
Completed

Summary

Conditions
Diabetes Mellitus
Type
Interventional
Phase
Phase 1
Design
  • Allocation: Randomized
  • Intervention Model: Crossover Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Min Age
20
Max Age
55
Gender
Male

Description

An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics After the Administration of HCP1201 Tablet 750/10 mg and Coadministration of Metformin SR 750 mg and Rosuvastatin 10 mg in Healthy Volunteers

An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics After the Administration of HCP1201 Tablet 750/10 mg and Coadministration of Metformin SR 750 mg and Rosuvastatin 10 mg in Healthy Volunteers

Locations

Seoul, 135-710
Seoul, 135-710

Tracking Information

NCT #
NCT02026817
Collaborators
Not Provided
Investigators
  • Principal Investigator: Jung-Ryul Kim, MD, PhD Samsung Medical Center
  • Jung-Ryul Kim, MD, PhD Samsung Medical Center